ANDREW MINZENMAYER
Dermatology Physician · TEMPLE, TX
Individual Active NPI 1588168629
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 222 | 603 | $108,337 | $27,591 | $17,470 |
| 2023 | 375 | 1,267 | $260,015 | $63,065 | $44,286 |
| 2022 | 197 | 507 | $112,074 | $27,463 | $21,335 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 17003 | Destruction of precancer skin growth, 2-14 growths | 181 | $2 | $1 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 91 | $63 | $39 |
| 17000 | Destruction of precancer skin growth, 1 growth | 62 | $46 | $31 |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 51 | $78 | $46 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 44 | $93 | $58 |
| 11102 | Biopsy of related skin growth, first growth | 43 | $27 | $16 |
| 17110 | Destruction of skin growth, 1-14 growths | 37 | $65 | $41 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 24 | $127 | $78 |
| 11103 | Biopsy of related skin growth, each additional growth | 17 | $20 | $13 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Dermatology Physician | 207N00000X | ✓ | T4983 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Dermatology Physician providers in Texas
- NPI 1982132957
- NPI 1275714545
- NPI 1013368851
- NPI 1073573150
- NPI 1841585890
- NPI 1700174075
- NPI 1902249840
- NPI 1841305869
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.